Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Oct 1;15(4):e20255329.
doi: 10.5826/dpc.1504a5329.

Skin-Immune-Neuro-Gastro-Endocrine (SINGE) System: Lighting the Fire on Atopic Dermatitis Research

Affiliations
Review

Skin-Immune-Neuro-Gastro-Endocrine (SINGE) System: Lighting the Fire on Atopic Dermatitis Research

Meshi Paz et al. Dermatol Pract Concept. .

Abstract

Introduction: Atopic dermatitis (AD) is a chronic inflammatory skin condition characterized by pruritic, dry, eczematous lesions. Traditionally regarded primarily as a cutaneous disorder influenced by genetic and environmental factors, AD is increasingly recognized as a multisystem condition involving immune, microbial, and neuroendocrine interactions.

Objectives: This review proposes the Skin-Immune-Neuro-Gastro-Endocrine (SINGE) network as a comprehensive framework to explore the interconnected pathophysiology of AD. The aim is to highlight how changes across various systems contribute to disease development, presentation, and treatment.

Methods: A comprehensive review of current literature was performed, examining the roles of skin barrier dysfunction, immune signaling, neuroendocrine pathways, and gut microbial dysbiosis. These domains were integrated into a unified model that describes bidirectional interactions and their clinical implications.

Results: The SINGE model reveals that epidermal barrier disruption activates a cascade of immune responses. Microbial dysbiosis, in concert with the gut-skin axis, further exacerbates AD symptoms, highlighting how alterations in one organ affect the other. Neuroinflammation further contributes to AD symptoms by perpetuating the itch-scratch cycle. Neuroendocrine factors amplify the inflammatory dysregulation, particularly through endocrine involvement involving cortisol signaling in the hypothalamic-pituitary-adrenal (HPA) axis and the paradoxical inflammatory effects on the skin barrier. Together, these intertwined pathways perpetuate the chronic inflammation and skin barrier dysfunction in AD.

Conclusion: By examining these elements as an intricate, intertwined system, the SINGE network reframes AD as a multisystem condition. This apprach not only shifts the understanding of the disease, but also serves as a foundation for exploration of targeted therapies.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: Dr. Peter Lio reports research grants/funding from AbbVie, AOBiome, and Regeneron/Sanofi, Genzyme, is on the speaker’s bureau for AbbVie, Eli Lilly, Galderma, Hyphens, Incyte, LEO Pharma, L'Oreal, MyOR Diagnostics, ParentMD, Pfizer, and Regeneron/Sanofi Genzyme, and reports consulting/advisory boards for AbbVie, Almirall, Amyris, AOBiome, Arbonne, ASLAN Pharmaceuticals, Burt’s Bees, Castle Biosciences, Codex Labs, Concerto Biosciences (stock options), Dermavant, Eli Lilly, Exeltis, Galderma, IntraDerm, Johnson & Johnson, LEO Pharma, L’Oreal, Menlo Therapeutics, Micreos, Pfizer, Pierre-Fabre, Regeneron/Sanofi Genzyme, Theraplex, and Unilever. In addition, Dr. Lio has a patent pending for a Theraplex product with royalties paid and is a Board member and Scientific Advisory Committee Member of the National Eczema Association. Meshi Paz reports no conflicts of interest.

Figures

Figure 1
Figure 1
The NICE System and Gut-Skin Axis. The NICE system (left) illustrates the multisystem crosstalk affecting skin health. The gut-skin axis (right) depicts the bidirectional communication between the two organs, suggesting that the dysfunction of one organ can influence the other. Expanding on these concepts, the SINGE network synthesizes both frameworks to provide a more comprehensive understanding of AD pathogenesis.
Figure 2
Figure 2
The Skin-Immune-Neuro-Gastro-Endocrine (SINGE) Network in atopic dermatitis (AD). The SINGE network illustrates the multisystem interactions involved in AD. Each system, interconnected by bidirectional communication, contributes to the cycle of disease progression in response to internal and external triggers.
Figure 3
Figure 3
Pathophysiology of atopic dermatitis (AD). In AD, the skin barrier dysfunction (1) allows allergens, irritants, and pathogens (2) to penetrate into the skin (3), activating an exaggerated Th2 immune response (4). The subsequent cytokine release, including IL-4, IL-5, IL-13, and IL-31 (5), further weakens the skin barrier integrity, leading to water loss and worsening symptoms (6).
Figure 4
Figure 4
The itch-scratch cycle. The itch-scratch cycle perpetuates skin damage and inflammation, driving the pruritus seen in atopic dermatitis. The itch sensation triggers a scratching response, which worsens inflammation and epidermal barrier damage, further fueling the cycle.

References

    1. Afshari M, Kolackova M, Rosecka M, Čelakovská J, Krejsek J. Unraveling the skin; a comprehensive review of atopic dermatitis, current understanding, and approaches. Frontiers in Immunology. 2024:15. doi: 10.3389/fimmu.2024.1361005. - DOI - PMC - PubMed
    1. Kolb L, Ferrer-Bruker SJ. Stat Pearls. Stat-Pearls Publishing; 2024. Atopic Dermatitis. - PubMed
    1. Magnifico I, Petronio Petronio G, Venditti N, et al. Atopic Dermatitis as a Multifactorial Skin Disorder. Can the Analysis of Pathophysiological Targets Represent the Winning Therapeutic miStrategy? Pharmaceuticals (Basel) 2020;13(11):411. doi: 10.3390/ph13110411. - DOI - PMC - PubMed
    1. Savva M, Papadopoulos NG, Gregoriou S, et al. Recent Advancements in the Atopic Dermatitis Mechanism. FBL. 2024;29(2):84. doi: 10.31083/j.fbl2902084. - DOI - PubMed
    1. Weidinger S, Novak N. Atopic dermatitis. The Lancet. 2016;387(10023):1109–1122. doi: 10.1016/S0140-6736(15)00149-X. - DOI - PubMed

LinkOut - more resources